Ute M. Kent

2.5k total citations
59 papers, 2.0k citations indexed

About

Ute M. Kent is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, Ute M. Kent has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pharmacology, 23 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Ute M. Kent's work include Pharmacogenetics and Drug Metabolism (41 papers), Drug Transport and Resistance Mechanisms (19 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Ute M. Kent is often cited by papers focused on Pharmacogenetics and Drug Metabolism (41 papers), Drug Transport and Resistance Mechanisms (19 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). Ute M. Kent collaborates with scholars based in United States, Bulgaria and Israel. Ute M. Kent's co-authors include Paul F. Hollenberg, Hsia-lien Lin, Namandjé N. Bumpus, Chitra Sridar, Theunis C. Goosen, Michael Aviram, J. Andrew Williams, H Metzger, Mira Rosenblat and Patrick Fleming and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Ute M. Kent

59 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ute M. Kent United States 26 1.1k 658 454 215 198 59 2.0k
Jean‐Charles Gautier France 27 1.2k 1.1× 852 1.3× 646 1.4× 239 1.1× 140 0.7× 60 2.8k
Roger J. Price United Kingdom 30 1.3k 1.1× 815 1.2× 558 1.2× 193 0.9× 118 0.6× 95 2.6k
Dan A. Rock United States 28 953 0.9× 633 1.0× 721 1.6× 187 0.9× 264 1.3× 68 2.1k
Cuyue Tang United States 25 839 0.8× 631 1.0× 627 1.4× 278 1.3× 206 1.0× 66 2.2k
Toshiro Niwa Japan 27 1.1k 1.0× 452 0.7× 505 1.1× 258 1.2× 128 0.6× 98 2.2k
David M. Stresser United States 29 1.4k 1.2× 822 1.2× 630 1.4× 198 0.9× 296 1.5× 54 2.5k
Robert L. Walsky United States 25 1.8k 1.6× 666 1.0× 927 2.0× 318 1.5× 370 1.9× 35 2.7k
Johannes Doehmer Germany 31 1.2k 1.1× 1.2k 1.9× 465 1.0× 199 0.9× 153 0.8× 106 2.9k
Liang‐Shang Gan United States 25 759 0.7× 843 1.3× 953 2.1× 220 1.0× 223 1.1× 43 2.4k
Fred K. Friedman United States 27 979 0.9× 1.3k 2.0× 744 1.6× 136 0.6× 211 1.1× 121 2.5k

Countries citing papers authored by Ute M. Kent

Since Specialization
Citations

This map shows the geographic impact of Ute M. Kent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute M. Kent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute M. Kent more than expected).

Fields of papers citing papers by Ute M. Kent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute M. Kent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute M. Kent. The network helps show where Ute M. Kent may publish in the future.

Co-authorship network of co-authors of Ute M. Kent

This figure shows the co-authorship network connecting the top 25 collaborators of Ute M. Kent. A scholar is included among the top collaborators of Ute M. Kent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute M. Kent. Ute M. Kent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shebley, Mohamad, Ute M. Kent, David P. Ballou, & Paul F. Hollenberg. (2009). Mechanistic Analysis of the Inactivation of Cytochrome P450 2B6 by Phencyclidine: Effects on Substrate Binding, Electron Transfer, and Uncoupling. Drug Metabolism and Disposition. 37(4). 745–752. 10 indexed citations
2.
3.
Snider, Natasha T., Andrei Kornilov, Ute M. Kent, & Paul F. Hollenberg. (2007). Anandamide Metabolism by Human Liver and Kidney Microsomal Cytochrome P450 Enzymes to Form Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acid Ethanolamides. Journal of Pharmacology and Experimental Therapeutics. 321(2). 590–597. 87 indexed citations
4.
Sridar, Chitra, et al.. (2006). Synthesis of Substituted Phenyl Diaziridines and Characterization as Mechanism-Based Inactivators of Human Cytochrome P450 2B6. Drug Metabolism and Disposition. 34(11). 1849–1855. 8 indexed citations
5.
Kobayashi, Yoshimasa, Chitra Sridar, Ute M. Kent, et al.. (2006). Structure-Activity Relationship and Elucidation of the Determinant Factor(s) Responsible for the Mechanism-Based Inactivation of Cytochrome P450 2B6 by Substituted Phenyl Diaziridines. Drug Metabolism and Disposition. 34(12). 2102–2110. 3 indexed citations
6.
Kent, Ute M., Hsia-lien Lin, Kathleen R. Noon, Danni L. Harris, & Paul F. Hollenberg. (2006). Metabolism of Bergamottin by Cytochromes P450 2B6 and 3A5. Journal of Pharmacology and Experimental Therapeutics. 318(3). 992–1005. 29 indexed citations
7.
Bumpus, Namandjé N., Chitra Sridar, Ute M. Kent, & Paul F. Hollenberg. (2005). THE NATURALLY OCCURRING CYTOCHROME P450 (P450) 2B6 K262R MUTANT OF P450 2B6 EXHIBITS ALTERATIONS IN SUBSTRATE METABOLISM AND INACTIVATION. Drug Metabolism and Disposition. 33(6). 795–802. 33 indexed citations
8.
Webster, Marie R., et al.. (2004). Metabolism of N,N′,N″-Triethylenethiophosphoramide by CYP2B1 and CYP2B6 Results in the Inactivation of Both Isoforms by Two Distinct Mechanisms. Journal of Pharmacology and Experimental Therapeutics. 310(3). 1011–1019. 22 indexed citations
9.
Lin, Hsia-lien, Ute M. Kent, Haoming Zhang, Lucy Waskell, & Paul F. Hollenberg. (2004). The Functional Role of Threonine-205 in the Mechanism-Based Inactivation of P450 2B1 by Two Ethynyl Substrates: The Importance of the F Helix in Catalysis. Journal of Pharmacology and Experimental Therapeutics. 311(3). 855–863. 8 indexed citations
10.
Kent, Ute M.. (2003). Purification of Antibodies Using Affinity Chromatography. Humana Press eBooks. 115. 23–28. 1 indexed citations
11.
Kent, Ute M., et al.. (2003). The Mechanism-Based Inactivation of Human Cytochrome P450 2B6 by Phencyclidine. Drug Metabolism and Disposition. 31(1). 46–52. 33 indexed citations
12.
Kent, Ute M.. (2003). Purification of Antibodies Using Protein A-Sepharose and FPLC. Humana Press eBooks. 115. 29–34. 2 indexed citations
13.
Javois, Lorette C., et al.. (2003). Overview of Antibody Use in Immunocytochemistry. Humana Press eBooks. 115. 3–10. 2 indexed citations
14.
Kent, Ute M., et al.. (2002). Effect of 17-α-Ethynylestradiol on Activities of Cytochrome P450 2B (P450 2B) Enzymes: Characterization of Inactivation of P450s 2B1 and 2B6 and Identification of Metabolites. Journal of Pharmacology and Experimental Therapeutics. 300(2). 549–558. 59 indexed citations
15.
Lin, Hsia-lien, Ute M. Kent, & Paul F. Hollenberg. (2002). Mechanism-Based Inactivation of Cytochrome P450 3A4 by 17α-Ethynylestradiol: Evidence for Heme Destruction and Covalent Binding to Protein. Journal of Pharmacology and Experimental Therapeutics. 301(1). 160–167. 106 indexed citations
16.
Sridar, Chitra, Ute M. Kent, L. Notley, Elizabeth M. J. Gillam, & Paul F. Hollenberg. (2002). Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6. Journal of Pharmacology and Experimental Therapeutics. 301(3). 945–952. 56 indexed citations
17.
Moreno, Rosa L., Theunis C. Goosen, Ute M. Kent, Fung‐Lung Chung, & Paul F. Hollenberg. (2001). Differential Effects of Naturally Occurring Isothiocyanates on the Activities of Cytochrome P450 2E1 and the Mutant P450 2E1 T303A. Archives of Biochemistry and Biophysics. 391(1). 99–110. 38 indexed citations
18.
Aviram, Michael, Ute M. Kent, & Paul F. Hollenberg. (1999). Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein. Atherosclerosis. 143(2). 253–260. 29 indexed citations
19.
Kent, Ute M.. (1994). Purification of Antibodies Using Ion-Exchange Chromatography. Humana Press eBooks. 34. 23–27. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Charles Gautier Breakdown of academic impact, for papers by Roger J. Price Breakdown of academic impact, for papers by Dan A. Rock Breakdown of academic impact, for papers by Cuyue Tang Breakdown of academic impact, for papers by Toshiro Niwa Breakdown of academic impact, for papers by David M. Stresser Breakdown of academic impact, for papers by Robert L. Walsky Breakdown of academic impact, for papers by Johannes Doehmer Breakdown of academic impact, for papers by Liang‐Shang Gan Breakdown of academic impact, for papers by Fred K. Friedman
Rankless by CCL
2026